AstraZeneca PLC (LON:AZN)

AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	209,450	213,845	162,287	164,292	173,826	134,436
Market Cap Growth	7.81%	31.77%	-1.22%	-5.49%	29.30%	39.84%
Enterprise Value	229,219	232,118	182,260	184,338	197,853	154,735
Last Close Price	140.42	135.58	100.74	99.82	103.48	78.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	25.40	28.15	28.88	35.14	63.70	1625.31
Forward PE	17.08	18.34	14.36	17.08	18.65	18.61
PS Ratio	4.63	4.90	3.76	4.57	4.72	4.87
PB Ratio	5.58	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	28.32	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	21.85	19.75	17.13	20.23	21.35	30.53
PEG Ratio	1.41	1.54	1.17	1.47	1.29	0.95

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	5.06	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	14.57	16.20	12.99	16.45	17.35	31.27
EV/EBIT Ratio	19.64	21.86	17.65	24.21	27.05	72.32
EV/FCF Ratio	30.89	26.55	22.96	26.14	27.35	43.01

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.66	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.58	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	3.36	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.51	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.23	1.24	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.56	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.53	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.69	1.81	1.80	1.59	1.26	1.85
Quick Ratio	0.79	0.65	0.67	0.58	0.62	0.67
Current Ratio	1.01	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	22.57%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.58%	8.19%	7.88%	6.13%	5.46%	2.10%
Return on Invested Capital (ROIC)	17.15%	17.03%	16.27%	13.42%	13.75%	6.00%
Return on Capital Employed (ROCE)	18.20%	17.10%	17.00%	13.70%	12.60%	3.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	3.94%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	3.53%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	1.77%	1.72%	2.37%	2.15%	2.15%	2.44%
Payout Ratio	43.82%	47.39%	65.47%	75.42%	132.72%	3442.86%
Buyback Yield / Dilution	0.02%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.72%	1.79%	2.30%	2.02%	-7.17%	-6.24%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error